IONIS PHARMACEUTICALS INC - Common Stock (IONS)
CUSIP: 462222100
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 165,242,218
- Total 13F shares
- 126,410,568
- Share change
- -9,355,570
- Total reported value
- $5,587,594,025
- Put/Call ratio
- 40%
- Price per share
- $44.23
- Number of holders
- 335
- Value change
- -$405,286,321
- Number of buys
- 142
- Number of sells
- 174
Quarterly Holders Quick Answers
What is CUSIP 462222100?
CUSIP 462222100 identifies IONS - IONIS PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 462222100:
Top shareholders of IONS - IONIS PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
13%
|
21,269,560
|
$787,399,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
9.1%
|
15,056,046
|
$557,375,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.4%
|
12,200,276
|
$451,653,000 | — | 30 Jun 2022 | |
| Bellevue Group AG |
13F
|
Company |
5.9%
|
9,776,528
|
$361,927,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
8,831,390
|
$326,937,000 | — | 30 Jun 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3.6%
|
6,005,818
|
$222,335,000 | — | 30 Jun 2022 | |
| ARK Investment Management LLC |
13F
|
Company |
2.8%
|
4,701,297
|
$171,691,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
4,202,874
|
$155,590,000 | — | 30 Jun 2022 | |
| Tweedy, Browne Co LLC |
13F
|
Company |
1.7%
|
2,726,778
|
$100,945,000 | — | 30 Jun 2022 | |
| Camber Capital Management LP |
13F
|
Company |
1.6%
|
2,700,000
|
$99,954,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,865,133
|
$69,047,000 | — | 30 Jun 2022 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.97%
|
1,596,055
|
$59,086,000 | — | 30 Jun 2022 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.77%
|
1,276,783
|
$47,267,000 | — | 30 Jun 2022 | |
| BVF INC/IL |
13F
|
Company |
0.77%
|
1,276,574
|
$47,259,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
1,154,025
|
$42,722,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.68%
|
1,118,341
|
$41,400,984 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.63%
|
1,041,824
|
$38,569,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.63%
|
1,039,570
|
$38,484,000 | — | 30 Jun 2022 | |
| Swedbank AB |
13F
|
Company |
0.62%
|
1,022,281
|
$37,844,842 | — | 30 Jun 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.49%
|
803,664
|
$29,752,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
737,977
|
$27,321,000 | — | 30 Jun 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.44%
|
723,995
|
$26,802,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.43%
|
705,811
|
$26,129,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.4%
|
665,315
|
$24,630,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
625,472
|
$23,155,000 | — | 30 Jun 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.37%
|
616,766
|
$22,833,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.37%
|
614,814
|
$22,760,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
608,552
|
$22,528,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.35%
|
585,048
|
$21,658,000 | — | 30 Jun 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.35%
|
570,692
|
$21,126,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
560,031
|
$20,732,000 | — | 30 Jun 2022 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.31%
|
515,859
|
$19,097,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.29%
|
480,143
|
$17,775,000 | — | 30 Jun 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.28%
|
468,116
|
$17,330,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.27%
|
453,400
|
$16,785,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.26%
|
428,423
|
$15,861,000 | — | 30 Jun 2022 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
0.28%
|
468,116
|
$15,448,000 | — | 30 Jun 2022 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.23%
|
375,977
|
$14,305,000 | — | 30 Jun 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
354,579
|
$13,127,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
348,686
|
$12,908,000 | — | 30 Jun 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.21%
|
340,716
|
$12,613,000 | — | 30 Jun 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.2%
|
325,985
|
$12,069,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
320,615
|
$11,869,000 | — | 30 Jun 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.19%
|
311,015
|
$11,514,000 | — | 30 Jun 2022 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.19%
|
306,320
|
$11,341,000 | — | 30 Jun 2022 | |
| DOWLING & YAHNKE LLC |
13F
|
Company |
0.18%
|
302,571
|
$11,201,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
299,300
|
$11,080,000 | — | 30 Jun 2022 | |
| Sicart Associates LLC |
13F
|
Company |
0.17%
|
288,751
|
$10,690,000 | — | 30 Jun 2022 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.17%
|
282,382
|
$10,454,000 | — | 30 Jun 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.14%
|
231,992
|
$9,220,000 | — | 30 Jun 2022 |
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q3 2022
As of 30 Sep 2022,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
335 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
126,410,568 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, ARK Investment Management LLC, and BVF INC/IL.
This page lists
336
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
329
Q3 2022 holders
335
Holder diff
6
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.